Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Rosemary J Tierney"'
Autor:
Laura L Quinn, Jianmin Zuo, Rachel J M Abbott, Claire Shannon-Lowe, Rosemary J Tierney, Andrew D Hislop, Martin Rowe
Publikováno v:
PLoS Pathogens, Vol 10, Iss 8, p e1004322 (2014)
CD8+ T cell responses to Epstein-Barr virus (EBV) lytic cycle expressed antigens display a hierarchy of immunodominance, in which responses to epitopes of immediate-early (IE) and some early (E) antigens are more frequently observed than responses to
Externí odkaz:
https://doaj.org/article/a908d79582d6406eb7c058c1e9359643
Autor:
Nenad, Sejic, Lindsay C, George, Rosemary J, Tierney, Catherine, Chang, Olga, Kondrashova, Ruth N, MacKinnon, Ping, Lan, Andrew I, Bell, Guillaume, Lessene, Heather M, Long, Andreas, Strasser, Claire, Shannon-Lowe, Gemma L, Kelly
Publikováno v:
Blood Adv
Epstein-Barr virus (EBV)–associated T- and natural killer (NK)–cell malignancies, such as extranodal NK-/T-cell lymphoma (ENKTL), exhibit high chemoresistance and, accordingly, such patients have a poor prognosis. The rare nature of such cancers
Autor:
Gemma L. Kelly, Marc Kvansakul, Clare Shannon-Lowe, Rosemary J. Tierney, Martin Rowe, Alan B. Rickinson, Laura C. A. Galbraith, D. Croom-Carter, Marco J Herold, Catherine Chang, Grant Dewson, Peter M. Colman, Rachel Cartlidge, Nenad Sejic, Andrew I. Bell, Andreas Strasser, Leah Fitzsimmons, David C.S. Huang, Chathura D. Suraweera
Publikováno v:
Cell Death Differ
Epstein–Barr virus (EBV), which is ubiquitous in the adult population, is causally associated with human malignancies. Like many infectious agents, EBV has evolved strategies to block host cell death, including through expression of viral homologue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8961400ef841ed9c400246b31e8c250c
https://europepmc.org/articles/PMC7206097/
https://europepmc.org/articles/PMC7206097/
Publikováno v:
Journal of Virology. 89:2483-2493
Epstein-Barr virus (EBV) infection of B cells leads to the sequential activation of two viral promoters, Wp and Cp, resulting in the expression of six EBV nuclear antigens (EBNAs) and the viral Bcl2 homologue BHRF1. The viral transactivator EBNA2 is
Autor:
Leah, Fitzsimmons, Andrew J, Boyce, Wenbin, Wei, Catherine, Chang, Deborah, Croom-Carter, Rosemary J, Tierney, Marco J, Herold, Andrew I, Bell, Andreas, Strasser, Gemma L, Kelly, Martin, Rowe
Publikováno v:
Cell Death and Differentiation
While the association of Epstein–Barr virus (EBV) with Burkitt lymphoma (BL) has long been recognised, the precise role of the virus in BL pathogenesis is not fully resolved. EBV can be lost spontaneously from some BL cell lines, and these EBV-loss
Autor:
Andrew I. Bell, Susan Phelan, Rosemary J. Tierney, Roya Hakimjavadi, Dermot Walls, Sinead M. Smith, Paul A. Cahill, Brendan N. D'Souza, Eva M. Campion, Sinéad T. Loughran
Publikováno v:
Journal of Virology. 88:5001-5013
The Epstein-Barr virus (EBV) establishes a lifelong latent infection in humans. EBV infection of primary B cells causes cell activation and proliferation, a process driven by the viral latency III gene expression program, which includes EBV nuclear p
Publikováno v:
Journal of Virology. 85:12362-12375
The genome of Epstein-Barr virus (EBV), a gammaherpesvirus with potent B-cell growth-transforming ability, contains multiple copies of a 3-kb BamHI W repeat sequence; each repeat carries (i) a promoter (Wp) that initiates transformation by driving EB
Autor:
Maho Koyama-Sato, Masahiro Yasui, Alan B. Rickinson, D. Croom-Carter, Keisei Kawa, Akihisa Sawada, Rosemary J. Tierney, Osamu Kondo, Masami Inoue
Publikováno v:
Journal of General Virology. 92:1032-1043
Polymorphisms in Epstein–Barr virus (EBV) latent genes can identify virus strains from different human populations and individual strains within a population. An Asian EBV signature has been defined almost exclusively from Chinese viruses, with lit
Autor:
Alan B. Rickinson, Wolfgang Hammerschmidt, Rosemary J. Tierney, Isabel A. Hutchings, Andrew I. Bell, Claire Shannon-Lowe, Markus Altmann, Jasdeep Nagra
Publikováno v:
J. Virol. 81, 10092-10100 (2007)
Epstein-Barr virus (EBV) can infect various cell types but limits its classical growth-transforming function to B lymphocytes, the cells in which it persists in vivo. Transformation initiates with the activation of Wp, a promoter present as tandemly
Autor:
Alan B. Rickinson, Julianna Stylianou, Gemma L. Kelly, Rosemary J. Tierney, Isabel A. Hutchings, Andrew I. Bell
Publikováno v:
Journal of Virology. 80:10700-10711
The Epstein-Barr virus (EBV) latent cycle promoter Wp, present in each tandemly arrayed copy of the BamHI W region in the EBV genome, drives expression of the EB viral nuclear antigens (EBNAs) at the initiation of virus-induced B-cell transformation.